52 research outputs found
Social networks as a means OF English language teachingof students of radiotechnic educational programms
The article is devoted to the study of the social network Vkontakte as a new element of information and communication technologies in the classroom of the English language teaching in higher education. Particular attention is paid to the integration of popular social networks in the educational process in order to further development of the educational material given in the classroom with students of radioelectronic educational programms of the Ural Federal University. Active and widespread use of mobile devices and social networks in everyday life ensures the relevance of their application for students. The purpose of this study is to determine the approaches and principles of teaching using social networks, to develop stages of work with social networks, to determine the actual methods of using social networks in the process of learning English.Π‘ΡΠ°ΡΡΡ ΠΏΠΎΡΠ²ΡΡΠ΅Π½Π° ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ ΡΠΎΡΠΈΠ°Π»ΡΠ½ΠΎΠΉ ΡΠ΅ΡΠΈ ΠΠΠΎΠ½ΡΠ°ΠΊΡΠ΅ Π² ΠΊΠ°ΡΠ΅ΡΡΠ²Π΅ Π½ΠΎΠ²ΠΎΠ³ΠΎ ΡΠ»Π΅ΠΌΠ΅Π½ΡΠ° ΠΈΠ½ΡΠΎΡΠΌΠ°ΡΠΈΠΎΠ½Π½ΠΎ-ΠΊΠΎΠΌΠΌΡΠ½ΠΈΠΊΠ°ΡΠΈΠΎΠ½Π½ΡΡ
ΡΠ΅Ρ
Π½ΠΎΠ»ΠΎΠ³ΠΈΠΉ Π½Π° Π·Π°Π½ΡΡΠΈΡΡ
Π°Π½Π³Π»ΠΈΠΉΡΠΊΠΎΠ³ΠΎ ΡΠ·ΡΠΊΠ° Π² Π²ΡΡΡΠ΅ΠΌ ΡΡΠ΅Π±Π½ΠΎΠΌ Π·Π°Π²Π΅Π΄Π΅Π½ΠΈΠΈ
Genotypes and Subtypes of Hepatitis B Virus Isolates in the Territory of Siberia
Identified are the occurrence, serotypic and genotypic variations of Hepatitis B virus isolates (HBV) among the Novosibirsk region inhabitants (n=2000), native population of the Alarsk District of the Irkutsk Region (n=487) and Shuryshkarsk Township of the Yamalo-Nenets Autonomous District (n=657). Occurrence rate of hepatitis Π surface antigen (HBsAg) among different groups of the Novosibirsk Region population varied within the limits of 3,6-35,0 %. It was 8,2 % in Alarsk District, and 3,2 % in Shuryshkarsk Township. HBV isolates of D genotype (92-97 %) prevail among the population of Siberia; few are the cases of A (1,7 %) and C (1,2-8 %) genotypes. The identified varying occurrence of HBV sub-genotypes and HBsAg subtypes in two aboriginal groups of Siberia (D3 sub-genotype and ayw2 subtype - in the Alarsk District, D2 and ayw3 - in Shuryshkarsk Township) suggests the existence of, at least, two isolated HBV virus populations, circulating among different groups of Siberia native population
A model of the artificial metastasis of human epidermoid carcinoma A431 in nude mice for examination of the oncolytic activity of vaccinia virus
Human carcinoma A431 cells were subcutaneously injected into nude mice at points remote from each other. One of the two xenografts developed afterΒwards was used for treatment with a recombinant vaccinia virus, while another served as an artificial metastasis. We used the attenuated recombinant vaccinia virus (VACV) VVdGF-GFP2 of the L-IVP strain (GenBank accession number KP233807), with deletion of two virulence genes: the virus growth factor and thymidine kinase, with the gene for the green fluorescent protein (GFP2) inserted in an area of the latter. Treatments were performed by a single intratumoral injection of the recombinant VACV at a dose of 107 PFU/mouse. VACV was detected in cells of the artificial metastasis as early as two days following infection, and after 8 days virus concentrations were com- parable with those in the infected tumor (~109 PFU/ml). Electron microscopy revealed selective replication of the recombinant in tumor cells. Targeted accumulation of GFP2 in both tumor and metastasis was shown in the UV-images of the mice obtained using theΒ In-vivo Multispectral Imaging System (Bruker, Germany). Complete destruction of the tumor was registered after 12 days, and that of metastasis, after 20 days post injection of VVdGF-GFP2. The destruction process was accompanied by pronounced edema and leukocyte infiltration of tumor tissue. The recombinant virus induced a significant reduction in the sizes of the tumor and metastasis: by the end of the experiment (35 days) the xenografts in the control mice were 10 times larger than those in the treated mice (5000 vs. 500 mm3). Our study showed that the attenuated VACV administered by the peripheral route not only is able to destroy theΒ primary tumor, but also has a distinct antimetaΒstatic action
Immunogenic and Protective Features of the Recombinant Vaccinia Virus Strain Expressing Cassette of Genes of Marburg Virus Structural Proteins
The aim of the study was to create a highly immunogenic vaccine construct based on a recombinant variant of a replication-defective MVA strain of vaccinia virus, expressing virus-like particles that mimic natural infection with Marburg virus. Materials and methods. The recombinant virus was obtained through recombination between homologous viral DNA sequences and the insertion plasmid pDel2-GP-VP-Pat which carries transgenes of the structural proteins GP and VP40 of Marburg virus, flanked by fragments of MVA strain genome. Structure of the recombinant virus was confirmed in PCR and using sequencing, transgenes expression was analyzed by Western blotting, viruslike particles formation was recorded using electron microscopy. Evaluation of immunogenicity and protectivity was carried out using a guinea pig model. The antibody titer was determined in enzyme-linked immunosorbent assay. To assess T-cell response, the intracellular staining of cytokines was used, followed by analysis of samples on a flow cytometer. Results and discussion. On the basis of highly attenuated MVA strain of vaccinia virus a recombinant variant MVA-GP-VP40-MARV has been constructed, carrying a cassette of transgenes, GP and VP40, of Marburg virus in the region of deletion II of the genome. The expression of transgenes in MVA-permissive CER cells infected with recombinant MVA-GP-VP40-MARV strain and secretion of GP and VP40 proteins into culture medium have been demonstrated. Electron microscopy analysis has revealed the presence of Marburg virus-like particles in the culture medium of cells 12 hours after infection. Double vaccination of guinea pigs with MVA-GP-VP40-MARV strain at a dose of 108 PFU/animal induced the formation of antibodies to Marburg and vaccinia viruses, as well as 100 % protection against lethal Marburg virus infection (50 LD50). Using original TEpredict software, the structure of T-helper epitopes of GP protein has been predicted. Using the ICS method, the biological activity of these epitopes has been experimentally confirmed and it was shown that they provide the induction of a T-cell immune response as part of the MVA-GP-VP40-MARV vaccine construct
Amyloid-Mediated Sequestration of Essential Proteins Contributes to Mutant Huntingtin Toxicity in Yeast
BACKGROUND: Polyglutamine expansion is responsible for several neurodegenerative disorders, among which Huntington disease is the most well-known. Studies in the yeast model demonstrated that both aggregation and toxicity of a huntingtin (htt) protein with an expanded polyglutamine region strictly depend on the presence of the prion form of Rnq1 protein ([PIN+]), which has a glutamine/asparagine-rich domain. PRINCIPAL FINDINGS: Here, we showed that aggregation and toxicity of mutant htt depended on [PIN+] only quantitatively: the presence of [PIN+] elevated the toxicity and the levels of htt detergent-insoluble polymers. In cells lacking [PIN+], toxicity of mutant htt was due to the polymerization and inactivation of the essential glutamine/asparagine-rich Sup35 protein and related inactivation of another essential protein, Sup45, most probably via its sequestration into Sup35 aggregates. However, inhibition of growth of [PIN+] cells depended on Sup35/Sup45 depletion only partially, suggesting that there are other sources of mutant htt toxicity in yeast. CONCLUSIONS: The obtained data suggest that induced polymerization of essential glutamine/asparagine-rich proteins and related sequestration of other proteins which interact with these polymers represent an essential source of htt toxicity
Π‘ΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅ ΠΈ ΠΈΠ·ΠΌΠ΅Π½ΡΠΈΠ²ΠΎΡΡΡ ΡΠ΅ΡΡΠΎΡΡΠ΅ΡΠΎΠ½Π° Ρ Π²Π·ΡΠΎΡΠ»ΡΡ ΠΈ ΠΌΠΎΠ»ΠΎΠ΄ΡΡ Π±Π°ΡΠ°Π½ΠΎΠ² ΡΠΎΠΌΠ°Π½ΠΎΠ²ΡΠΊΠΎΠΉ ΠΏΠΎΡΠΎΠ΄Ρ
In the article, the authors conducted a comprehensive study of the interior, including biochemical, physiological, physicochemical, cytogenetic, and other indicators in sheep of the Romanov breed of Western Siberia. For the study, blood serum samples were taken from 10 rams-producers and 30 lambs at four months. Conventional methods took blood samples. Analyses were performed in the biochemistry laboratory of Novosibirsk State Agrarian University using the technique of competitive enzyme immunoassay with the reagent kit βSteroidIFAtestosteroneβ for the quantitative determination of testosterone concentration in blood serum. In the sheep breeding area, the authors constantly monitored the content of heavy metals in water, soil, feed, organs, and tissues. The concentration of chemical elements did not exceed the permissible exposure limit. Enzyme-linked immunosorbent assay was performed on a Thermo Scientific Multiskan FC analyzer. The authors performed statistical processing of experimental data using standard methods of descriptive statistics, the statistical programming language, or the RStudio data analysis environment (using the functions DescrStats, Summary, Sd, Read. Table, Write. Table, Aes). The authors established the influence of the age of ontogenesis on the testosterone content in Romanov rams. Presented figure with two variation curves with high transgression. The average testosterone level was 1.8 times higher in lambs (0.774 mmol/l) than in lambs. Testosterone concentration was characterized by high phenotypic variability. The authors have identified reference intervals for testosterone in blood serum depending on environmental conditions in sheep of the Romanov breed of Western Siberia.Π£ ΠΎΠ²Π΅Ρ ΡΠΎΠΌΠ°Π½ΠΎΠ²ΡΠΊΠΎΠΉ ΠΏΠΎΡΠΎΠ΄Ρ Π² ΠΠ°ΠΏΠ°Π΄Π½ΠΎΠΉ Π‘ΠΈΠ±ΠΈΡΠΈ ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΡΡΡ ΠΊΠΎΠΌΠΏΠ»Π΅ΠΊΡΠ½ΠΎΠ΅ ΠΈΠ·ΡΡΠ΅Π½ΠΈΠ΅ ΠΈΠ½ΡΠ΅ΡΡΠ΅ΡΠ°, Π²ΠΊΠ»ΡΡΠ°ΡΡΠ΅Π΅ Π±ΠΈΠΎΡ
ΠΈΠΌΠΈΡΠ΅ΡΠΊΠΈΠ΅, ΡΠΈΠ·ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠ΅, ΡΠΈΠ·ΠΈΠΊΠΎ-Ρ
ΠΈΠΌΠΈΡΠ΅ΡΠΊΠΈΠ΅, ΡΠΈΡΠΎΠ³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΈ Π΄ΡΡΠ³ΠΈΠ΅ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΠΈ. ΠΠ»Ρ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ Π²Π·ΡΡΡ ΠΏΡΠΎΠ±Ρ ΡΡΠ²ΠΎΡΠΎΡΠΊΠΈ ΠΊΡΠΎΠ²ΠΈ Ρ 10 Π±Π°ΡΠ°Π½ΠΎΠ² - ΠΏΡΠΎΠΈΠ·Π²ΠΎΠ΄ΠΈΡΠ΅Π»Π΅ΠΉ ΠΈ 30 Π±Π°ΡΠ°Π½ΡΠΈΠΊΠΎΠ² Π² Π²ΠΎΠ·ΡΠ°ΡΡΠ΅ 4 ΠΌΠ΅ΡΡΡΠ΅Π². ΠΠ±ΡΠ°Π·ΡΡ ΠΊΡΠΎΠ²ΠΈ ΠΎΡΠΎΠ±ΡΠ°Π½Ρ ΠΏΠΎ ΠΎΠ±ΡΠ΅ΠΏΡΠΈΠ½ΡΡΡΠΌ ΠΌΠ΅ΡΠΎΠ΄ΠΈΠΊΠ°ΠΌ. ΠΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΠ»ΠΈΡΡ Π² Π»Π°Π±ΠΎΡΠ°ΡΠΎΡΠΈΠΈ Π±ΠΈΠΎΡ
ΠΈΠΌΠΈΠΈ ΠΠΎΠ²ΠΎΡΠΈΠ±ΠΈΡΡΠΊΠΎΠ³ΠΎ Π³ΠΎΡΡΠ΄Π°ΡΡΡΠ²Π΅Π½Π½ΠΎΠ³ΠΎ Π°Π³ΡΠ°ΡΠ½ΠΎΠ³ΠΎ ΡΠ½ΠΈΠ²Π΅ΡΡΠΈΡΠ΅ΡΠ° Ρ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ ΠΌΠ΅ΡΠΎΠ΄Π° ΠΊΠΎΠ½ΠΊΡΡΠ΅Π½ΡΠ½ΠΎΠ³ΠΎ ΠΈΠΌΠΌΡΠ½ΠΎΡΠ΅ΡΠΌΠ΅Π½ΡΠ½ΠΎΠ³ΠΎ Π°Π½Π°Π»ΠΈΠ·Π° Ρ Π½Π°Π±ΠΎΡΠΎΠΌ ΡΠ΅Π°Π³Π΅Π½ΡΠΎΠ² Β«Π‘ΡΠ΅ΡΠΎΠΈΠ΄ΠΠ€Π-ΡΠ΅ΡΡΠΎΡΡΠ΅ΡΠΎΠ½Β» Π΄Π»Ρ ΠΊΠΎΠ»ΠΈΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΎΠ³ΠΎ ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΡ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΠΈ ΡΠ΅ΡΡΠΎΡΡΠ΅ΡΠΎΠ½Π° Π² ΡΡΠ²ΠΎΡΠΎΡΠΊΠ΅ ΠΊΡΠΎΠ²ΠΈ. Π Π·ΠΎΠ½Π΅ ΡΠ°Π·Π²Π΅Π΄Π΅Π½ΠΈΡ ΠΎΠ²Π΅Ρ ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΠ»ΡΡ ΠΏΠΎΡΡΠΎΡΠ½Π½ΡΠΉ ΠΌΠΎΠ½ΠΈΡΠΎΡΠΈΠ½Π³ ΡΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΡ ΡΡΠΆΠ΅Π»ΡΡ
ΠΌΠ΅ΡΠ°Π»Π»ΠΎΠ² Π² Π²ΠΎΠ΄Π΅, ΠΏΠΎΡΠ²Π΅, ΠΊΠΎΡΠΌΠ°Ρ
, ΠΎΡΠ³Π°Π½Π°Ρ
ΠΈ ΡΠΊΠ°Π½ΡΡ
. ΠΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΡ Ρ
ΠΈΠΌΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΠ»Π΅ΠΌΠ΅Π½ΡΠΎΠ² Π½Π΅ ΠΏΡΠ΅Π²ΡΡΠ°Π»Π° ΡΡΠΎΠ²Π½Ρ ΠΠΠ. ΠΠΌΠΌΡΠ½ΠΎΡΠ΅ΡΠΌΠ΅Π½ΡΠ½ΡΠΉ Π°Π½Π°Π»ΠΈΠ· ΠΏΡΠΎΠ²Π΅Π»ΠΈ Π½Π° Π°Π½Π°Π»ΠΈΠ·Π°ΡΠΎΡΠ΅ Thermo Scientific Multiskan FC. Π‘ΡΠ°ΡΠΈΡΡΠΈΡΠ΅ΡΠΊΠ°Ρ ΠΎΠ±ΡΠ°Π±ΠΎΡΠΊΠ° ΡΠΊΡΠΏΠ΅ΡΠΈΠΌΠ΅Π½ΡΠ°Π»ΡΠ½ΡΡ
Π΄Π°Π½Π½ΡΡ
ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΠ»Π°ΡΡ Ρ ΠΏΠΎΠΌΠΎΡΡΡ ΡΡΠ°Π½Π΄Π°ΡΡΠ½ΡΡ
ΠΌΠ΅ΡΠΎΠ΄ΠΎΠ² ΠΎΠΏΠΈΡΠ°ΡΠ΅Π»ΡΠ½ΠΎΠΉ ΡΡΠ°ΡΠΈΡΡΠΈΠΊΠΈ ΠΈ ΡΠ·ΡΠΊΠ° ΡΡΠ°ΡΠΈΡΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΏΡΠΎΠ³ΡΠ°ΠΌΠΌΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΠΈΠ»ΠΈ ΡΡΠ΅Π΄Ρ Π°Π½Π°Π»ΠΈΠ·Π° Π΄Π°Π½Π½ΡΡ
RStudio (ΠΏΡΠΈ ΠΏΠΎΠΌΠΎΡΠΈ ΡΡΠ½ΠΊΡΠΈΠΉ descrstats, summary, sd, read.table, write. table, aes). ΠΡΠ»ΠΎ ΡΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½ΠΎ Π²Π»ΠΈΡΠ½ΠΈΠ΅ Π²ΠΎΠ·ΡΠ°ΡΡΠ° ΠΎΠ½ΡΠΎΠ³Π΅Π½Π΅Π·Π° Π½Π° ΡΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅ ΡΠ΅ΡΡΠΎΡΡΠ΅ΡΠΎΠ½Π° Ρ Π±Π°ΡΠ°Π½ΠΎΠ² ΡΠΎΠΌΠ°Π½ΠΎΠ²ΡΠΊΠΎΠΉ ΠΏΠΎΡΠΎΠ΄Ρ. ΠΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½ ΡΠΈΡΡΠ½ΠΎΠΊ Ρ Π΄Π²ΡΠΌΡ Π²Π°ΡΠΈΠ°ΡΠΈΠΎΠ½Π½ΡΠΌΠΈ ΠΊΡΠΈΠ²ΡΠΌΠΈ Ρ Π²ΡΡΠΎΠΊΠΎΠΉ ΡΡΠ°Π½ΡΠ³ΡΠ΅ΡΡΠΈΠ΅ΠΉ. Π‘ΡΠ΅Π΄Π½ΠΈΠΉ ΡΡΠΎΠ²Π΅Π½Ρ ΡΠ΅ΡΡΠΎΡΡΠ΅ΡΠΎΠ½Π° Π±ΡΠ» Π²ΡΡΠ΅ Π² 1,8 ΡΠ°Π·Π° Ρ Π±Π°ΡΠ°Π½ΠΎΠ²-ΠΏΡΠΎΠΈΠ·Π²ΠΎΠ΄ΠΈΡΠ΅Π»Π΅ΠΉ (0,774 ΠΌΠΌΠΎΠ»Ρ/Π»), ΡΠ΅ΠΌ Ρ Π±Π°ΡΠ°Π½ΡΠΈΠΊΠΎΠ². ΠΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΡ ΡΠ΅ΡΡΠΎΡΡΠ΅ΡΠΎΠ½Π° Ρ
Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΠ·ΠΎΠ²Π°Π»Π°ΡΡ Π²ΡΡΠΎΠΊΠΎΠΉ ΡΠ΅Π½ΠΎΡΠΈΠΏΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΈΠ·ΠΌΠ΅Π½ΡΠΈΠ²ΠΎΡΡΡΡ. ΠΡΡΠ²Π»Π΅Π½Ρ ΡΠ΅ΡΠ΅ΡΠ΅Π½ΡΠ½ΡΠ΅ ΠΈΠ½ΡΠ΅ΡΠ²Π°Π»Ρ ΠΏΠΎ ΡΠ΅ΡΡΠΎΡΡΠ΅ΡΠΎΠ½Ρ Π² ΡΡΠ²ΠΎΡΠΎΡΠΊΠ΅ ΠΊΡΠΎΠ²ΠΈ Π² Π·Π°Π²ΠΈΡΠΈΠΌΠΎΡΡΠΈ ΠΎΡ ΡΠΊΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΡΠ»ΠΎΠ²ΠΈΠΉ Ρ Π±Π°ΡΠ°Π½ΠΎΠ² ΡΠΎΠΌΠ°Π½ΠΎΠ²ΡΠΊΠΎΠΉ ΠΏΠΎΡΠΎΠ΄Ρ ΠΠ°ΠΏΠ°Π΄Π½ΠΎΠΉ Π‘ΠΈΠ±ΠΈΡΠΈ
- β¦